GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Swedencare AB (OTCPK:SWDCF) » Definitions » Research & Development

Swedencare AB (Swedencare AB) Research & Development : $0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Swedencare AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Swedencare AB's Research & Development for the three months ended in Mar. 2024 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $0.0 Mil.

Swedencare AB Research & Development Historical Data

The historical data trend for Swedencare AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Swedencare AB Research & Development Chart

Swedencare AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Swedencare AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Swedencare AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Swedencare AB  (OTCPK:SWDCF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Swedencare AB Research & Development Related Terms

Thank you for viewing the detailed overview of Swedencare AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Swedencare AB (Swedencare AB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Swedencare AB (OTCPK:SWDCF) » Definitions » Research & Development
Comparable Companies
OSTO:BIOG B OSTO:PROB OSTO:CRNO B XSAT:EQL OSTO:ENZY OSTO:ORX OSTO:ALZCUR OSTO:MOB OSTO:ERMA OSTO:VIVE ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
SECARE:Sweden 0ABG:UK 7XY:Germany
Address
Per Albin Hanssons Vag 41, Medeon Science Park, Malmo, SWE, 205 12
Website
https://www.swedencare.se
Swedencare AB is specialized in pet healthcare and produces partly in own factories, markets and sells premium products on the global market. The company has a wide range of brands and products within most therapy areas, which includes Animal Pharmaceuticals, nutravet, NutriScience, PetMD, Stratford, VetWELL as well as ProDen PlaqueOff for oral health to dogs and cats. The company's products are sold in approximately fifty markets.

Swedencare AB (Swedencare AB) Headlines

No Headlines